Company profile SNTI

Senti Biosciences Inc.
senti biosciences is a team of engineers, scientists, and entrepreneurs on a mission to leverage synthetic biology to treat the most pressing diseases. they have pioneered new technology platforms to design synthetic gene circuits for adaptive cell and gene therapies. their recently completed series a round of funding will be used to further the growth of their scalable therape...utic design platform and advance therapeutic candidates towards the clinic. they are proud to count nea, 8vc, amgen ventures, pear ventures, lux capital, menlo ventures, allen & company, nest.bio, omega funds, goodman capital, and lifeforce capital among their investors. Show More
Quarter analysis & expected interest

There is not enough data for Senti Biosciences -gene -earnings to provide analysis

Correlation between past revenue and Senti Biosciences -gene -earnings search interest

There is not enough data for Senti Biosciences -gene -earnings to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Senti Biosciences -gene -earnings to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Senti Biosciences SNTI stock news to provide analysis

Correlation between past revenue and Senti Biosciences SNTI stock news search interest

There is not enough data for Senti Biosciences SNTI stock news to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Senti Biosciences SNTI stock news to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Senti Biosciences headquarters to provide analysis

Correlation between past revenue and Senti Biosciences headquarters search interest

There is not enough data for Senti Biosciences headquarters to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Senti Biosciences headquarters to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for SNTI careers to provide analysis

Correlation between past revenue and SNTI careers search interest

There is not enough data for SNTI careers to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for SNTI careers to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Senti Biosciences IPO to provide analysis

Correlation between past revenue and Senti Biosciences IPO search interest

There is not enough data for Senti Biosciences IPO to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Senti Biosciences IPO to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Senti Biosciences pipeline to provide analysis

Correlation between past revenue and Senti Biosciences pipeline search interest

There is not enough data for Senti Biosciences pipeline to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Senti Biosciences pipeline to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Senti Biosciences stock price to provide analysis

Correlation between past revenue and Senti Biosciences stock price search interest

There is not enough data for Senti Biosciences stock price to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Senti Biosciences stock price to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for SNTI preclinical biotechnology to provide analysis

Correlation between past revenue and SNTI preclinical biotechnology search interest

There is not enough data for SNTI preclinical biotechnology to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for SNTI preclinical biotechnology to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for SNTI
Earnings date: 2024-03-04 After close
Company name: Senti Biosciences Inc.
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-15T12:17:57Z

Analyst Upgrades
Chardan Capital Maintains Buy on Senti Biosciences, Raises Price Target to $12

2026-05-14T12:45:00Z

GlobeNewswire
Senti Biosciences Holdings Reports First Quarter 2026 Financial Results and Highlights Advancement of SENTI-202 Program into Pivotal Phase

2026-05-14T12:40:00Z

GlobeNewswire
Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program

2026-04-24T16:06:17-04:00

SEC
8-K12B Form - Notification that a class of securities of successor issuer is deemed to be registered pursuant to section 12(b), items 1.01, 1.02, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01, and 9.01 - Senti Biosciences, Inc. (0001854270) (Filer)

2026-04-13T13:00:00Z

GlobeNewswire
Senti Biosciences to Present on Logic-Gated Cell Therapies in Educational Session at AACR Annual Meeting 2026

2026-04-01T12:45:00Z

GlobeNewswire
Senti Biosciences Announces Publication in Cell Systems Demonstrating Advanced Logic-Gated CAR Design for Cell Therapies

2026-03-30T11:58:30Z

Analyst Upgrades
Chardan Capital Maintains Buy on Senti Biosciences, Lowers Price Target to $11

2026-03-27T12:00:00Z

GlobeNewswire
Senti Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update

2026-03-23T13:00:00Z

GlobeNewswire
Senti Biosciences to Present Clinical and Translational Data on SENTI-202 at the 11th Annual Innate Killer Conference

2026-03-03T14:05:00Z

GlobeNewswire
Senti Biosciences to Present at Leerink Partners 2026 Global Healthcare Conference

2026-02-24T14:15:00Z

GlobeNewswire
Senti Biosciences to Present at TD Cowen 46th Annual Health Care Conference

2026-02-20T13:50:00Z

GlobeNewswire
Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development

2026-02-11T13:35:00Z

GlobeNewswire
Senti Biosciences Completes Enrollment in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)

2026-02-03T14:00:00Z

GlobeNewswire
Senti Biosciences Selected for On-Stage Presentation at Healthcare Conference Taipei 2026

2026-01-14T14:15:00Z

GlobeNewswire
Senti Biosciences Participates in Virtual Investor CEO Connect Segment to Discuss the Company's Groundbreaking AML Data at the American Society of Hematology Annual Meeting and Recently Granted RMAT Designation